BioWa Inc. - Articles and news items

Lonza and BioWa sign license agreements with Pfizer, Inc.

News, Supplier news / 30 July 2013 / Lonza

BioWa, Inc. and Lonza have entered into research agreements with Pfizer Inc. allowing the use of the POTELLIGENT® CHOK1SV Cell Line in the research and development of multiple proprietary antibodies in Pfizer’s pipeline…

Lonza and Biowa sign license agreements with FivePrime Therapeutics

News, Supplier news / 13 June 2012 / Lonza

FivePrime has entered into research & commercial agreements with BioWa & Lonza…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+